Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.
[waldenström macroglobulinemia]
Non-
Hodgkin
lymphoma
(
NHL
)
,
the
most
common
hematologic
malignancy
,
consists
of
numerous
subtypes
.
The
etiology
of
NHL
is
incompletely
understood
,
and
increasing
evidence
suggests
that
risk
factors
may
vary
by
NHL
subtype
.
However
,
small
numbers
of
cases
have
made
investigation
of
subtype-
specific
risks
challenging
.
The
International
Lymphoma
Epidemiology
Consortium
therefore
undertook
the
NHL
Subtypes
Project
,
an
international
collaborative
effort
to
investigate
the
etiologies
of
NHL
subtypes
.
This
article
describes
in
detail
the
project
rationale
and
design
.
We
pooled
individual-level
data
from
20
case-control
studies
(
17471
NHL
cases
,
23096
controls
)
from
North
America
,
Europe
,
and
Australia
.
Centralized
data
harmonization
and
analysis
ensured
standardized
definitions
and
approaches
,
with
rigorous
quality
control
.
The
pooled
study
population
included
11
specified
NHL
subtypes
with
more
than
100
cases
:
diffuse
large
B-
cell
lymphoma
(
N
=
4667
)
,
follicular
lymphoma
(
N
=
3530
)
,
chronic
lymphocytic
leukemia
/
small
lymphocytic
lymphoma
(
N
=
2440
)
,
marginal
zone
lymphoma
(
N
=
1052
)
,
peripheral
T-
cell
lymphoma
(
N
=
584
)
,
mantle
cell
lymphoma
(
N
=
557
)
,
lymphoplasmacytic
lymphoma
/
Waldenström
macroglobulinemia
(
N
=
374
)
,
mycosis
fungoides
/
Sézary
syndrome
(
N
=
324
)
,
Burkitt
/
Burkitt-like
lymphoma
/
leukemia
(
N
=
295
)
,
hairy
cell
leukemia
(
N
=
154
)
,
and
acute
lymphoblastic
leukemia
/
lymphoma
(
N
=
152
)
.
Associations
with
medical
history
,
family
history
,
lifestyle
factors
,
and
occupation
for
each
of
these
11
subtypes
are
presented
in
separate
articles
in
this
issue
,
with
a
final
article
quantitatively
comparing
risk
factor
patterns
among
subtypes
.
The
International
Lymphoma
Epidemiology
Consortium
NHL
Subtypes
Project
provides
the
largest
and
most
comprehensive
investigation
of
potential
risk
factors
for
a
broad
range
of
common
and
rare
NHL
subtypes
to
date
.
The
analyses
contribute
to
our
understanding
of
the
multifactorial
nature
of
NHL
subtype
etiologies
,
motivate
hypothesis-driven
prospective
investigations
,
provide
clues
for
prevention
,
and
exemplify
the
benefits
of
international
consortial
collaboration
in
cancer
epidemiology
.
Diseases
Validation
Diseases presenting
"cancer"
symptom
achondroplasia
acute rheumatic fever
adrenal incidentaloma
alpha-thalassemia
benign recurrent intrahepatic cholestasis
cadasil
canavan disease
carcinoma of the gallbladder
cholangiocarcinoma
coats disease
congenital adrenal hyperplasia
congenital diaphragmatic hernia
cowden syndrome
cushing syndrome
cutaneous mastocytosis
dedifferentiated liposarcoma
dystrophic epidermolysis bullosa
epidermolysis bullosa simplex
erdheim-chester disease
erythropoietic protoporphyria
esophageal adenocarcinoma
esophageal carcinoma
esophageal squamous cell carcinoma
familial hypocalciuric hypercalcemia
familial mediterranean fever
gm1 gangliosidosis
heparin-induced thrombocytopenia
hereditary cerebral hemorrhage with amyloidosis
hirschsprung disease
hodgkin lymphoma, classical
inclusion body myositis
junctional epidermolysis bullosa
kabuki syndrome
kallmann syndrome
kindler syndrome
lamellar ichthyosis
liposarcoma
locked-in syndrome
lymphangioleiomyomatosis
monosomy 21
neuralgic amyotrophy
oculocutaneous albinism
oligodontia
oral submucous fibrosis
papillon-lefèvre syndrome
pendred syndrome
pleomorphic liposarcoma
primary effusion lymphoma
proteus syndrome
pyomyositis
pyruvate dehydrogenase deficiency
severe combined immunodeficiency
sneddon syndrome
systemic capillary leak syndrome
triple a syndrome
von hippel-lindau disease
waldenström macroglobulinemia
well-differentiated liposarcoma
werner syndrome
wiskott-aldrich syndrome
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
This symptom has already been validated